purine has been researched along with Bowel Diseases, Inflammatory in 6 studies
1H-purine : The 1H-tautomer of purine.
3H-purine : The 3H-tautomer of purine.
9H-purine : The 9H-tautomer of purine.
7H-purine : The 7H-tautomer of purine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Reports have shown an increased risk of melanoma skin cancer (MSC) with exposure to tumor necrosis factor alpha (TNF-α) inhibitors and non-melanoma skin cancer (NMSC) with thiopurine exposure in inflammatory bowel disease (IBD) patients." | 7.80 | Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System. ( Deepak, P; McKenna, MR; Stobaugh, DJ, 2014) |
| "Reports have shown an increased risk of melanoma skin cancer (MSC) with exposure to tumor necrosis factor alpha (TNF-α) inhibitors and non-melanoma skin cancer (NMSC) with thiopurine exposure in inflammatory bowel disease (IBD) patients." | 3.80 | Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System. ( Deepak, P; McKenna, MR; Stobaugh, DJ, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haglund, S | 1 |
| Almer, S | 1 |
| Peterson, C | 1 |
| Söderman, J | 1 |
| de Boer, NK | 1 |
| de Meij, T | 1 |
| van Bodegraven, AA | 1 |
| McKenna, MR | 1 |
| Stobaugh, DJ | 1 |
| Deepak, P | 1 |
| Kurashima, Y | 1 |
| Kiyono, H | 1 |
| Kunisawa, J | 1 |
| Sharara, AI | 1 |
| Kotlyar, DS | 1 |
| Osterman, MT | 1 |
| Diamond, RH | 1 |
| Porter, D | 1 |
| Blonski, WC | 1 |
| Wasik, M | 1 |
| Sampat, S | 1 |
| Mendizabal, M | 1 |
| Lin, MV | 1 |
| Lichtenstein, GR | 1 |
3 reviews available for purine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
[Purinergic signaling mediates mast cell activation in intestinal inflammation].
Topics: Adenosine Triphosphate; Animals; Humans; Inflammatory Bowel Diseases; Mast Cells; Mice; Purines; Rec | 2014 |
When to Start Immunomodulators in Inflammatory Bowel Disease?
Topics: Drug Therapy, Combination; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Methotrexate; P | 2016 |
A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Humans; Immunologic Factors; | 2011 |
3 other studies available for purine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Gene expression and thiopurine metabolite profiling in inflammatory bowel disease - novel clues to drug targets and disease mechanisms?
Topics: Gene Expression Profiling; Gene Expression Regulation; Glucocorticoids; Humans; Inflammatory Bowel D | 2013 |
Thiopurines during pregnancy in inflammatory bowel disease: is there a risk for the (unborn) child?
Topics: Anti-Inflammatory Agents; Azathioprine; Female; Fetus; Gastrointestinal Agents; Humans; Inflammatory | 2013 |
Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents; Databases, Fac | 2014 |